Clinical Trials in Phoenix

Showing 9201-9220 of 12,606 trials

BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.

NCT00931801

The purpose of this Phase IV pilot study is to evaluate the safety, tolerability, and satisfaction of a nucleoside analog reverse-transcriptase inhibitors (NRTI)sparing regimen for participants fully suppressed on an atazanavir/ritonavir based highly active antiretroviral therapy (HAART)regimen plus emtricitabine/tenofovir (Truvada). Several pharmacologic factors support this concept including the favorable drug interaction between atazanavir and raltegravir. Participants will be randomized to either continue on their current regimen or one of two study arms (atazanavir 300mg plus ritonavir 100mg daily plus raltegravir 400mg twice daily or atazanavir 300mg twice daily plus raltegravir 400mg twice daily). Participants will be followed for 48 weeks for safety, tolerability, and satisfaction. After baseline, the participants will have six clinic visits for evaluation and labs.

HIV

Community Research Initiative of New England43 participantsStarted Dec 2009

Phoenix, Arizona, United States • Los Angeles, California, United States • Denver, Colorado, United States +6 more locations

COMPLETEDPhase 2< 1 mile

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

NCT00335556

This phase II trial is studying how well combination chemotherapy, radiation therapy, and/or surgery work in treating patients with high-risk kidney tumors. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving combination chemotherapy together with radiation therapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed.

Childhood Renal Cell CarcinomaClear Cell Renal Cell CarcinomaClear Cell Sarcoma of the Kidney+10 more

Children's Oncology Group291 participantsStarted Jun 2006

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Mobile, Alabama, United States +184 more locations

BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Find Trials by Condition in Phoenix

Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)

ARI103094-Follow-Up Study for REDUCE Study Subjects

A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of Age

Assessment of Sympathetic Nervous System Activity by Microneurography Recording Technique

Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study

GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers

Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma

A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects

Treatment Of Patients With Social Anxiety Disorder

Telephone Support to Improve Adherence to Anti-HIV Medications

A Screening Protocol to Assess Adults and Adolescents With Down Syndrome for Eligibility For Upcoming Study of RG1662 (Study BP27832)

A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer

Digital Mammography Screening Trial (ACRIN6652)

Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young Women

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

Pharmacokinetics & Safety of Diclofenac Potassium Oral Solution in Ped. Subjects (2-12 Yrs) With Mild-Mod. Acute Pain

Mastectomy Reconstruction Outcomes Consortium (MROC) Study

H7N9 Mix and Match With MF59 in Healthy Elderly Persons